Somatostatin induced SSTR2A endocytosis is regulated through b arrestin2 arf6 EFA6A PLD1 cascade in panceratic b cells (RINm5F)

  Somatostatin-induced SSTR2A endocytosis is regulated through β-arrestin2Arf6-EFA6A-PLD1 cascade in pancreatic β-cells (RINm5F) by Dai Tan Vo A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Biomedical Sciences (Pharmacology) Program of Study Committee: Walter H Hsu, Major Professor Steven Carlson Timothy A Day Anumantha G Kanthasamy Michael J Kimber Richard J Martin Iowa State University Ames, Iowa 2011 ii   TABLE OF CONTENTS ABSTRACT iii LIST OF ABBREVIATIONS iv CHAPTER 1: GENERAL INTRODUCTION CHAPTER 2: MATERIALS AND METHODS 22 CHAPTER 3: RESULTS 30 CHAPTER 4: DISCUSSION 66 REFERENCES 74 ACKNOWLEDGEMENTS 93 iii     ABSTRACT Somatostatin (SS) receptors (SSTRs) undergo endocytosis following agonist stimulation We investigated the mechanism underlying SS-induced SSTR2A endocytosis The results from our previous work demonstrated that SS increases phospholipase D (PLD1) activity through Gβγ leading to the increase in phosphatidylinositol 4,5-bisphosphate (PIP2) levels in clonal β-cells HIT-T15 We also demonstrated that Arf6 and EFA6A are involved in the SS-induced PLD activity in HIT-T15 In the present study, we found that in clonal β-cells (RINm5F) overexpressing SSTR2A, SS-14 evoked endocytosis of these receptors By using radioligand binding techniques, we found that β-arrestin2, the ADP/ATP exchange factor for Arf6 A (EFA6A), ADP-ribosylation factor (Arf6), and PLD1 partcipated in the SS-induced SSTR2A endocytosis In addition, immunoprecipitation results showed the bindings between βarrestin2 and Arf6, Arf6 and EFA6A, and Arf6 and PLD1 Taken together, our findings strongly support the hypothesis that SS-induced SSTR2A endocytosis is mediated by the β-arrestin2- Arf6-EFA6A-PLD1 cascade in cell model system Therefore, we proposed a novel mechanism regarding SSTR2A endocytosis pathway in which via Gi/o-coupled SSTR2A, SS activates Gβγ, which triggers the GRK2 to phosphorylate SSTR2A, which is followed by recruitment of βarrestin2 β-Arrestin2 then forms the β-arrestin2-EFA6A complex in the cytosol and translocates it to the plasma membrane to activate Arf6 The activated Arf6 will stimulate PLD1 to catalyze the formation of phosphatidic acid (PA) from phosphatidyl choline (PC) PA then serves as a cofactor to activate phosphatidylinositol 4-phosphate-5-kinase (PIP5K) to increase PIP2 formation PIP2 ultimately recruits endocytic proteins such as adaptor protein (AP2) and clathrin to form vesicle-coat pits, resulting in SSTR endocytosis in β-cells iv     LIST OF ABBREVIATIONS AC: Adenylyl cyclase AP2: Adapter protein Arf6: ADP-ribosylation factor ARNO: Arf Nucleotide-binding site Opener Bax: Bcl-2–associated X protein β- Arr: β–arrestin cAMP: cyclic adenosine monophosphate cGMP: cyclic guanosine monophosphate CHO: Chinese hamster ovary DAG: Dicylglycerol DAPI: 4’,6-diamidino-2-phenylindole dilactate dn: dominant negative EDTA: Ethylenediaminetetraacetic acid EFA6: Guanine nucleotide exchange factor for Arf6 EFA6A: Guanine nucleotide exchange factor for Arf6 A EGFR: Epidermal growth factor receptor Erk: extracellular signal-regulated kinases FBS: Fetal bovine serum FLAG-tag: polypeptide protein tag GAPs: GTPase-activating proteins GEFs: Guanine nucleotide Exchange Factors GH: Growth hormone GIT1: G protein-coupled receptor interacting protein GPCRs: G protein-coupled receptors GRKs: G protein-coupled receptor kinases GRP: Cytohesin/general Receptor for Phosphoinosittides HA: Hemagglutinin HEK: Human embryonic kidney HRP: Horseradish peroxidase v     IP3: Inositol-1,4,5-triphosphate JNK: c-Jun-N-terminus kinase KRB: Krebs Ringer Buffer MAPK: Mitogen-activated protein kinases NHE: Na+/H+ exchanger PA: Phosphatidic acid PC: Phosphatidylcholine PH: Pleckstrin homology PKA: Protein kinase A PKC: Protein kinase C PI3: Phosphatidylinositol-3 PIP2: Phosphatidylinositol-4-5-biphosphate PIP3: Phosphatidylinositol 3,4,5-triphosphate PIP4Ks: Phosphatidylinositol 5-phosphate 4-kinases PIP5K: Phosphatidylinositol 4-phosphate-5-kinase PLA2: Phospholipase A2 PLC-β: Phospholipase C-β PLD: Phospholipase D PTP: Protein tyrosine phosphatase RINm5F: Rat insulinoma m5F RIPA: radioimmunoprecipitation assay SDS-PAGE: sodium dodecyl sulfate polyacrylamide gel electrophoresis si-RNA: Small interfering RNA SS: Somatostatin SSTRs: Somatostatin receptors STAT3: Signal transducer and activator of transcription TSH: Thyroid-stimulating hormon     CHAPTER 1: GENERAL INTRODUCTION DISSERTATION ORGANIZATION This dissertation contains four chapters Chapter1: The general introduction includes a research objective, background information and literature review Chapter 2: Materials and Methods Chapter 3: Results: SS-induced SSTR2A endocytosis is mediated by β-arrestin2, Arf6, EFA6A and phospholipase D1 signaling pathway Chapter 4: General discussion and future research In addition, a list of references cited and acknowledgements are included RESEARCH OBJECTIVES Endocytosis or internalization of G protein-coupled receptors (GPCRs) is a process that is induced when extracellular agonists bind to surface receptors There are many signaling proteins participating in the endocytosis pathway of GPCRs such as G protein- coupled receptor kinases (GRKs), β-arrestins, ADP-ribosylation factor (Arf6), phospholipase D (PLD), phosphatidylinositol-4-5-biphosphate (PIP2), and adapter protein (AP2), (Doherty and McMahon, 2009; Houndolo et al., 2005; Sorkin and von Zastrow, 2009) Somatostatin (SS) receptors (SSTRs) undergo endocytosis following the agonist stimulation (Roosterman et al., 2008; Duran-Prado et al., 2007; Liu et al., 2005) However, the signaling pathway of SS-induced SSTR endocytosis is not well-understood In a previous study, we found that SS stimulated PLD activity and promoted PIP2 synthesis in β-cells (Cheng et al., 2005) We also demonstrated that in β-cells SS- stimulated PLD activity was mediated by a guanine nucleotide exchange factor for Arf6 A (EFA6A) (Grodnitzky et al., 2007) In addition, results from our preliminary study showed that upon SS stimulation SSTR2A underwent endocytosis Therefore, we hypothesized that β-arrestins, Arf6, EFA6A, and PLD participate in the SS-induced SSTR2A endocytosis signaling pathway The proposed pathway is shown in Scheme The objective of this dissertation is to     elucidate the role of four important signal proteins (β-arrestins, EFA6A, Arf6, and PLD) and their interrelationships in the SS-induced SSTR2A endocytosis pathway We used the rat insulinoma m5F (RINm5F) cell line transiently overexpressed with SSTR2A as a model We used radioligand binding techniques to demonstrate endocytosis To knockdown the signaling genes we either used small interfering RNA (si-RNA) techniques or overexpressed dominant negative (dn) constructs to generate mutant signaling proteins In addition, we used immunoprecipitation technique to investigate the interactions between signaling proteins     BACKGROUND AND LITERATURE REVIEW Somatostatin (SS) SS, a peptide hormone, was first discovered from the extraction of hypothalamus as a tetradecapeptide and inhibited secretion of growth hormone (Brazeau et al., 1973) Subsequently, SS was found to be secreted from many other tissues including δcells of pancreatic islets of Langerhans, nervous systems, and gastrointestinal mucosa, and in a small amount from the thyroid, adrenals, submandibular glands, kidneys, prostate, and placenta (Patel, 1999) It exists in two biologically active forms, SS-14 (14 amino acids) and SS-28 (28 amono acids) Both isoforms are derived from the proteolytic cleavage of the prosomatostatin (a 92-amino-acid protein), which is derived from a precursor of 116-amino-acid preprosomatostatin (Figure 1) SS has a potent inhibitory effect on the secretion of many hormones, including growth hormone (GH), thyroid-stimulating hormone (TSH), insulin and glucagon from the pancreas, and a number of gastrointestinal hormones such as gastrin, secretin, cholecystokinin, motilin, gastric inhibitory polypeptide and vasoactive intestinal peptide (Bloom and Polak, 1987; Kumar and Grant, 2010) Figure Somatostatin processing and amino acids order of SS-14 and SS-28 PreproSS: preprosomatostatin; proSS: prosomatostatin     SS receptors and their distribution There are five genes on different chromosomes encoding five different SS receptor subtypes (SSTR1, SSTR2, SSTR3, SSTR4, and SSTR5) The name SSTR1-5 was based on the order of discoveries SSTR1 and SSTR2 were identified by Yamada et al (1992) Soon after that the rest of SSTRs (SSTR3, SSTR4, and SSTR5) were cloned and characterized (Patel et al., 1995, 1996; Patel, 1997) SSTRs have the sizes from 356 to 391 amino acids and have overall sharing of 39-57% sequence homology The most divergences are at the N- and C-terminal segments SSTR2 exists in two spliced variants named SSTR2A and SSTR2B; they are different at the C-terminus and are encoded on the same chromosome 17 SSTR2A is a physiologically active isoform between two of them (Barnett, 2003) SSTRs distribute in many cells/tissues, including brain, pituitary, islets, stomach, kidneys, liver, placenta, and lungs (Patel, 1999; Tulipano and Schulz, 2007; Olias et al., 2004) However, the distribution of SSTRs is not equal in all tissues There is usually more than one SSTR subtype in each cell or tissue SSTR1 is predominantly expressed in the brain and is also found in the pituitary, islets, and adrenals SSTR2 is predominantly expressed in many normal tissued including brain, vessels, nerve plexuses, adrenal medulla, spleen, kidneys, prostatic stroma, and pancreatic islets (Reubi et al., 2001; Liu et al., 2007; Reubi, 2003) The expression of SSTRs in neoplastic tissues is much higher in density than normal tissues in which SSTR2 is the most frequently expressed receptors of tumors (Reubi et al., 2001; Reubi, 2003; Liu et al., 2005) SSTR2 also has high affinity for SS analogs, therefore; SSTR2 is the most investigated SS receptor SSTR3 is highly expressed in the cerebellum, but less in the rest of the brain SSTR3 is also highly expressed in the spleen, kidneys, and the liver (Taniyama et al., 2005) SSTR4 is poorly expressed in the brain, but abundantly expressed in the heart and moderately expressed in the lungs and islets SSTR5 is prominent in the     pituitary, intestine, and islets, but poorly expressed in the brain (Taniyama et al., 2005) SS receptor signaling The actions of SS are mediated through SSTRs that are coupled to pertussis toxinsensitive Gi/o subfamily They are all GPCRs with seven transmembrane-spanning domains (TM1-7) (Patel, 1999; Lahlou et al., 2004), which are connected by three extracellular and three intracellular loops (Hu et al., 2010) G protein structures and actions GPCRs are activated by extracellular ligands, leading the receptors to interact with and activate G proteins G proteins are composed of three subunits (α, β, and γ) and are referred to heterotrimeric G proteins They are activated by diverse ligands, which vary from single photons through ions, odorants, amino acids, fatty acids, neurotransmitters, peptides/polypeptides, and proteins Upon activation, the GPCRs undergo conformational changes leading to the activation of G proteins by the exchange of GDP/GTP at Gα subunit The Gβγ dimer then dissociates from the Gα subunit Both moieties are active to stimulate downstream effectors and thereby initiate unique intracellular signaling responses (Tuteja, 2009) In humans, there are 21 Gα subunits encoded by 16 genes, Gβ subunits encoded by genes and 12 Gγ subunits encoded by 12 genes (Downes & Gautam, 1999) Based on sequence homology and functional similarities of α subunits, heterotrimeric G proteins can be grouped into four subfamilies: Gs stimulates adenylyl cyclase (AC); Gi/o inhibits AC and voltage-dependent Ca2+ channels, and acitvates K+ channels; Gq/11 activates phospholipase C-β (PLC-β); and G12 activates Rho, a small G protein, through linking with a Rho GEF G protein functions for SSTRs Following the agonist stimulation, all SSTRs inhibit AC (Patel et al., 1994); leading to the reduction of intracellular cAMP concentrations Protein kinase A (PKA) is then 79     Florio T, Yao H, Carey KD, Dillon TJ, and Stork PJ (1999) Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor (SSTR1) Mol Endocrinol 13:24–37 Franco M, Boretto J, Robineau S, Monier S, Goud B, Chardin P and Chavrier P (1998) ARNO3, a Sec7-domain guanine nucleotide exchange factor for ADP ribosylation factor 1, is involved in the control of golgi structure and function Proc Natl Acad Sci USA 95:9926–9931 Franco M, Peters PJ, Boretto J, van Donselaar E, Neri A, D'Souza-Schorey C, and Chavrier P (1999) EFA6, a sec7 domain-containing exchange factor for ARF6, coordinates membrane recycling and actin cytoskeleton organization EMBO J 18:1480-1491 Frank S, Upender S, Hansen SH, and Casanova JE (1998) ARNO is a guanine nucleotide exchange factor for ADP-ribosylation factor J Biol Chem 273:23–27 Furman C, Short SM, Subramanian RR, Zetter BR, and Roberts TM (2002) DEF1/ ASAP1 is a GTPase-activating protein (GAP) for Arf1 that enhances cell motility through a GAP-dependent mechanism J Biol Chem 277:7962–7969 Gaidarov I, and Keen JH (1999) Phosphoinositide-AP-2 interactions required for targeting to plasma membrane clathrin-coated pits J Cell Biol 146:755-764 Gillingham AK, and Muno S (2007) The small G proteins of the Arf family and their regulators Annu Rev Cell Dev Biol 23:579-611 Grant BD, and Donaldson JG (2009) Pathways and mechanisms of endocytic recycling Nat Rev Mol Cell Biol 10(9):597-608 Grodnitzky JA, Syed N, Kimber MJ, Day TA, Donaldson JG, and Hsu WH (2007) Somatostatin receptors signal through EFA6A-Arf6 to activate phospholipase D in clonal beta-cells J Biol Chem 282(18):13410-13418 80     Haucke V (2005) Phosphoinositide regulation of clathrin-mediated endocytosis Biochem Soc Trans 33:1285-1289 Hernandez-Deviez DJ, Roth MG, Casanova JE, and Wilson JM (2004) ARNO and Arf6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol 4-phosphate 5-kinase alpha Mol Biol Cell 15:111-120 Heuser JE, and Anderson RG (1989) Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation J Cell Biol 108(2):389-400 Hipkin RW, Friedman J, Clark RB, Eppler CM, and Schonbrunn A (1997) Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor J Biol Chem 272(21):13869-13876 Hodgkin MN, Masson MR, Powner D, Saqib KM, Ponting CP, and Wakelam MJ (2000) Phospholipase D regulation and localisation is dependent upon a phosphatidylinositol 4,5-biphosphate-specific PH domain Curr Biol 10(1):43-46 Hoefen RJ, and Berk BC (2006) The multifunctional GIT family of proteins J Cell Sci 119:1469–1475 Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe H, Kawamoto K, Nakayama K, Morris AJ, Frohman MA, and Kanaho Y (1999) Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein Arf6 in membrane ruffle formation Cell 99(5):521-532 Hou C, Gilbert RL, and Barber DL (1994) Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2 J Biol Chem 269:10357–10362 Houndolo T, Boulay PL, and Claing A (2005) G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells J Biol Chem 280(7):55985604 81     Hu J, Wang Y, Zhang X, Lloyd JR, Li JH, Karpiak J, Costanzi S, and Wess J (2010) Structural basis of G protein-coupled receptor-G protein interactions Nat Chem Biol 6(7):541-548 Ikeda SR, and Schofield GG (1989) Somatostatin blocks a calcium current in rat sympathetic ganglion neurones J Physiol 409:221–240 Inoue H, and Randazzo PA (2007) Arf GAPs and their interacting proteins Traffic 8(11):1465-1475 Ishihara H, Shibasaki Y, Kizuki N, Katagiri H, Yazaki Y, Asano T, and Oka Y (1996) Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase J Biol Chem 271:23611-23614 Jackson CL, and Casanova JE (2000) Turning on Arf: the Sec7 family of guaninenucleotide-exchange factors Trends Cell Biol 10(2):60-67 Jackson TR, Brown FD, Nie Z, Miura K, Foroni L, Sun J, Hsu VW, Donaldson JG, and Randazzo PA (2000) ACAPs are Arf6 GTPase-activating proteins that function in the cell periphery J Cell Biol 151:627–638 Jacobs S, and Schulz S (2007) Intracellular trafficking of somatostatin receptors Mol Cell Endocrinol 286(1-2):58-62 Jenkins GM and Frohman MA (2005) Phospholipase D: a lipid centric review Cellular and Molecular Life Science 62:2305-2316 Jost M, Simpson F, Kavran JM, Lemmon MA, and Schmid SL (1998) Phosphatidylinositol-4,5-bisphosphate is required for endocytic coated vesicle formation Curr Biol 8(25):1399-1402 Kahn RA, Bruford E, Inoue H, Logsdon JM Jr, Nie Z, Premont RT, Randazzo PA, Satake M, Theibert AB, Zapp ML, and Cassel D (2008) Consensus 82     nomenclature for the human ArfGAP domain-containing proteins J Cell Biol 182(6):1039-44 Kang YS, Zhao X, Lovaas J, Eisenberg E, and Greene LE (2009) Clathrinindependent internalization of normal cellular prion protein in neuroblastoma cells is associated with the Arf6 pathway J Cell Sci 122(Pt 22):4062-4069 Kato T, Kumai A, Okamoto R (1993) Effect of beta-endorphin on cAMP and progesterone accumulation in rat luteal cells Endocr J 40(3):323-328 Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, and Wittig B (1991) Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents Nature 353:43–48 Koch T, Brandenburg LO, Liang Y, Schulz S, Beyer A, Schroder H, and Hollt V (2004) Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization J Neurochem 88(3):680-688 Koenig JA, Kaur R, Dodgeon I, Edwardson JM, and Humphrey PP (1998) Fates of endocytosed somatostatin sst2 receptors and associated agonists Biochem J 336 (Pt 2):291-298 Kohout TA, Lin FS, Perry SJ, Conner DA, and Lefkowitz RJ (2001) beta-Arrestin and differentially regulate heptahelical receptor signaling and trafficking Proc Natl Acad Sci U S A 98(4):1601-1606 Kreuzer OJ, Krisch B, De’ry O, Bunnett NW, and Meyerhof W (2001) Agonistmediated endocytosis of rat somatostatin receptor subtype involves beta-arrestin and clathrin coated vesicles J Neuroendocrinol 13(3):279-287 Krupnick JG, and Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation Annu Rev Pharmacol Toxicol 38:289-319 83     Krugmann S, Anderson KE, Ridley SH, Risso N, McGregor A, Coadwell J, Davidson K, Eguinoa A, Ellson CD, Lipp P, Manifava M, Ktistakis N, Painter G, Thuring JW, Cooper MA et al (2002) Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices Mol Cell 9:95–108 Kumar U, and Grant M (2010) Somatostatin and somatostatin receptors Results Probl Cell Differ 50:137-184 Lahlou H, Saint-Laurent N, Esteve JP, Eyche’ne A, Pradayrol L, Pyronnet S, and Susini C (2003) sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation J Biol Chem 278:39356–39371 Lahlou H, Guillermet J, Hortala M, Vernejoul F, Pyronnet S, Bousquet C, and Susini C (2004) Molecular signaling of somatostatin receptors Ann N Y Acad Sci 1014:121-31 Lamberts SW, Krenning EP, and Reubi JC (1991) The role of somatostatin and its analogs in the diagnosis and treatment of tumors Endocr Rev 12:450–482 Lefkowitz RJ, and Shenoy SK (2005) Transduction of receptor signals by betaarrestins Science 308(5721):512-517 Lamberts SW, Pieters GF, Metselaar HJ, Ong GL, Tan HS, and Reubi JC (1988) Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours Acta Endocrinol (Copenh) 119(4):561-566 Lanoix J, Ouwendijk J, Lin CC, Stark A, Love HD, Ostermann J, and Nilsson T (1999) GTP hydrolysis by Arf-1 mediates sorting and concentration of Golgi resident enzymes into functional COP I vesicles EMBO J 18:4935–4948 Lin CY, Varma MG, Joubel A, Madabushi S, Lichtarge O, and Barber DL (2003) Conserved motifs in somatostatin, D2- dopamine, and alpha 2B-adrenergic 84     receptors for inhibiting the Na-H exchanger, NHE1 J Biol Chem 278:15128– 15135 Liscovitch M, Czarny M, Fiucci G, Lavie Y, Tang X (1999) Localization and possible functions of phospholipase D isozymes Biochim Biophys Acta 1439(2):245-63 Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC, and Schronbrunn A (2005) Receptor signaling and endocytosis are differentially regulated by somatostatin analogs Mol Pharmacol 68(1):90-101 Liu Y, Yerushalmi GM, Grigera PR, and Parsons JT (2005b) Mislocalization or reduced expression of Arf GTPase-activating protein ASAP1 inhibits cell spreading and migration by influencing Arf1 GTPase cycling J Biol Chem 280:8884–8892 Liu Q, Dewi DA, Liu W, Bee MS, and Schonbrunn A (2007) Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding Mol Pharmacol 73(2):292-304 Loijens JC, and Anderson RA (1996) Type I phosphatidylinositol-4-phosphate 5kinases are distinct members of this novel lipid kinase family J Biol Chem 271:32937- 32943 Lopez I, Arnold RS, and Lambeth JD (1998) Cloning and initial characterization of a human phospholipase D2 (hPLD2) ADP-ribosylation factor regulates hPLD2 J Biol Chem 273(21):12846-12852 Luttrell LM, and Lefkowitz RJ (2002) The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals J Cell Sci 115:455-465 Ma L, and Pei G (2007) Beta-arrestin signaling and regulation of transcription J Cell Sci 120(Pt 2):213-218 85     Macia E, Luton F, Partisani M, Cherfils J, Chardin P, and Franco M (2004) The GDP-bound form of Arf6 is located at the plasma membrane J Cell Sci 117:23892398 Marchese A, Paing MM, Temple BR, and Trejo J (2008) G protein-coupled receptor sorting to endosomes and lysosomes Annu Rev Pharmacol Toxicol 48:601-629 Martin A, Brown FD, Hodgkin MN, Bradwell AJ, Cook SJ, Hart M, and Wakelam MJ (1996) Activation of phospholipase D and phosphatidylinositol 4- phosphate 5kinase in HL60 membranes is mediated by endogenous Arf but not Rho J Biol Chem 271:17397-17403 Martin TF (2001) PIP2 regulation of surface membrane traffic Curr Opin Cell Biol 13(4):493-499 Matsuya S, Sakagami H, Tohgo A, Owada Y, Shin HW, Takeshima H, Nakayama K, Kokubun S, and Kondo H (2005) Cellular and subcellular localization of EFA6C, a third member of the EFA6 family, in adult mouse Purkinje cells J Neurochem 93:674-685 Miura K, Jacques KM, Stauffer S, Kubosaki A, Zhu K, Hirsch DS, Resau J, Zheng Y, and Randazzo PA (2002) ARAP1: a point of convergence for Arf and Rho signaling Mol Cell 9:109–119 Moore CA, Milano SK, and Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins Annu Rev Physiol 69:451-482 Moritz A, Westerman J, De Graan PN, and Wirtz KW (1992) Phosphatidylinositol 4-kinase and phosphatidylinositol-4-phosphate 5-kinase from bovine brain membranes Methods Enzymol 209:202-211 Murthy KS, Coy DH, and Makhouf GM (1996) Somatostatin receptor-mediated signaling in smooth muscle Activation of phospholipase C-beta3 by Gbetagamma 86     and inhibition of adenylyl cyclase by Galphai1 and Galphao J Biol Chem 271(38):23458-63 Nie Z, Stanley KT, Stauffer S, Jacques KM, Hirsch DS, Takei J, and Randazzo PA (2002) AGAP1, an endosome-associated, phosphoinositide- dependent ADPribosylation factor GTPase-activating protein that af- fects actin cytoskeleton J Biol Chem.277:48965–48975 Nie Z, Fei J, Premont RT, and Randazzo PA (2005) The Arf GAPs AGAP1 and AGAP2 distinguish between the adaptor protein complexes AP-1 and AP-3 J Cell Sci 118:3555–3566 Oberg KE (2009) Is it time to widen the use of somatostatin analogs in neuroendocrine tumors? J Clin Oncol 27(28):4635-4636 Olias G, Viollet C, Kusserow H, Epelbaum J, and Meyerhof W (2004) Regulation and function of somatostatin receptors J Neurochem 89(5):1057-1091 Patel YC, Greenwood MT, Warszynska A, Panetta R, and Srikant C.B (1994) All five cloned human somatostatin receptors (hSSTR1– 5) are functionally coupled to adenylyl cyclase Biochem Biophys Res Commun 198:605–612 Patel YC, Greenwood MT, Panetta R, Demchyshyn L, Niznik H, and Srikant CB (1995) The somatostatin receptor family Life Sci 57:1249–1265 Patel YC, Greenwood M, Panetta R, Hukovic N, Grigorakis S, Robertson LA, and Srikant CB (1996) Molecular biology of somatostatin receptor sub- types Metabolism 45:31–38 Patel YC (1997) Molecular pharmacology of somatostatin receptor subtypes J Endocrinol Invest 20:348–367 Patel YC (1999) Somatostatin and its receptor family Front Neuroendocrinol 20(3):157-198 87     Peyroche A, Paris S, and Jackson CJ (1996) Nucleotide exchange on Arf mediated by yeast Geal protein Nature 384:479-481 Poupart ME, Fessart D, Cotton M, Laporte SA, and Claing A (2007) Arf6 regulates angiotensin II type receptor endocytosis by controlling the recruitment of AP-2 and clathrin Cell Signal 19(11):2370-2378 Powner DJ, Hodgkin MN, Wakelam MJ (2002) Antigen-stimulated activation of phospholipase D1b by Rac1, ARF6, and PKCalpha in RBL-2H3 cells Mol Biol Cell 13(4):1252-1262 Praefcke GJ, and McMahon HT (2004) The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 5(2):133-147 Premont RT, Claing A, Vitale N, Freeman JLR, Pitcher JA, Patton WA, Moss J, Vaughan M, and Lefkowitz RJ (1998) β2-adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPaseactivating protein Proc Natl Acad Sci USA 95:14082 – 14087 Rankovic M, Jacob L, Rankovic V, Brandenburg LO, Schroder H, Hollt V, and Koch T (2009) ADP-ribosylation factor regulates mu-opioid receptor trafficking and signaling via activation of phospholipase D2 Cell Signal 21(12):1784-1793 Reiter E, and Lefkowitz RJ (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling Trends Endocrinol Metab 17(4):159-165 Reubi JC, Waser B, Schaer JC, and Laissue JA (2001) Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur J Nucl Med 28(7):836-846 Reubi JC 2003 Peptide receptors as molecular targets for cancer diagnosis and therapy Endocr Rev 24:389–427 88     Roosterman D, Glassmeier G, Baumeister H, Scherubl H, and Meyerhof W (1998) A somatostatin receptor selective ligand inhibits Ca2+ currents in rat insulinoma 1046-38 cells FEBS Lett 425:137–140 Roosterman D, Brune NE, Kreuzer OJ, Feld M, Pauser S, Zarse K, Steinhoff M, and Meyerhof W (2008) Intracellular degradation of somatostatin-14 following somatostatin-receptor3-mediated endocytosis in rat insulinoma cells FEBS J 275(19):4728-4739 Roosterman D, Kreuzer OJ, Brune N, Cottrell GS, Bunnett NW, Meyerhof W, and Steinhoff M (2007) Agonist-induced endocytosis of rat somatostatin receptor Endocrinology 172(3):1050-1058 Roosterman D, Roth A, Kreienkamp HJ, Richter D, and Meyerhof W (1997) Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells J Neuroendocrinol 9(10):741-751 Roth A, Kreienkamp HJ, Nehring RB, Roosterman D, Meyerhof W, and Richter D (1997) Endocytosis of the rat somatostatin receptors: subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs DNA Cell Biol 16(1):111-119 Sakagami H (2008) The EFA6 family: guanine nucleotide exchange factors for ADP ribosylation factor at neuronal synapses Tohoku J Exp Med 214:191-198 Sellers LA (1999) Prolonged activation of extracellular signal-regulated kinase by a protein kinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors J Biol Chem 274(34):24280-24288 Sellers LA, Alderton F, Carruthers AM, Schindler M, Humphrey PP (2000) Receptor isoforms mediate opposing proliferative effects through gbetagammaactivated p38 or Akt pathways Mol Cell Biol 20:5974–5985 89     Sharma K, Patel YC and Srikant CB (1996) Subtype-selective induction of wildtype p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor Mol Endocrinol 10:1688–1696 Sharma K, and Srikant CB (1998) Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells Int J Cancer 76:259–266 Sharma K, Patel YC, Srikant CB (1999) C-terminal region of human somatostatin receptor is required for induction of Rb and G1 cell cycle arrest Mol Endocrinol 13(1):82-90 Shen Y, Xu L, and Foster DA (2001) Role for phospholipase D in receptormediated endocytosis Mol Cell Biol 21(2):595-602 Shiina T, Arai K, Tanabe S, Yoshida N, Haga T, Nagao T, and Kurose H (2001) Clathrin box in G protein-coupled receptor kinase J Biol Chem 276(35):3301933026 Sims SM, Lussier BT and Kraicer J (1991) Somatostatin activates an inwardly rectifying K+ conductance in freshly dispersed rat so- matotrophs J Physiol 441:615–637 Schweitzer P, Madamba S, and Siggins GR (1990) Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current Nature 346:464–467 Sharma K, Patel YC and Srikant CB (1999) C-terminal region of human somatostatin receptor is required for induction of Rb and G1 cell cycle arrest Mol Endocrinol 13: 82–90 Smalley KS, Feniuk W, Sellers LA, and Humphrey PP (1999) The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst(4) receptor-mediated 90     stimulation of p44/p42 mitogen-activated protein kinase and extracellular acidification Biochem Biophys Res Commun 263:239–243 Sorkin A, and von Zastrow M (2009) Endocytosis and signalling: intertwining molecular networks Nat Rev Mol Cell Biol 10(9):609-622 Spang A, Shiba Y, and Randazzo PA (2010) Arf GAPs: gatekeepers of vesicle generation FEBS Lett 584(12):2646-2651 Sun Y, Carroll S, Kaksonen M, Toshima JY, and Drubin DG (2007) PIP2 turnover is required for multiple stages during clathrin- and actin-dependent endocytic internalization J Cell Biol 177(2):355-367 Tallent M, Liapakis G, O’Carroll AM, Lolait SJ, Dichter M, and Reisine T (1996) Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20 Neuroscience 71:1073–1081 Tanigawa G, Orci L, Amherdt M, Ravazzola M, Helms JB, and Rothman JE (1993) Hydrolysis of bound GTP by Arf protein triggers uncoating of Golgi- derived COP-coated vesicles J Cell Biol 123:1365–1371 Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, and Sasano H (2005) Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study Endocr J 52(5):605-611 Teijeiro R, Rios R, Costoya JA, Castro R, Bello JL, Devesa J, and Arce VM (2002) Activation of human SSTR2 promotes apoptosis through a mechanism that is independent from induction of p53 Cell Physiol Biochem 12:31–38 Tsuga H, Kameyama K, Haga T, Kurose H, and Nagao T (1994) Sequestration of muscarinic acetylcholine receptor M2 subtypes Facilitation by GRK2 and attenuation by a dominant-negative mutant of GRK2 J Biol Chem 269(51):3252232527 91     Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V, and Schulz S (2004) Differential β-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes J Biol Chem 279(20):21374-21382 Tulipano G, and Schulz S (2007) Novel insights in somatostatin receptor physiology Eur J Endocrinol 156(1):3-11 Tuteja N (2009) Signaling through G protein coupled receptors Plant signal Behav 4(10):942-947 Van den Bout I, and Divecha N (2009) PIP5K-driven PIP2 synthesis: regulation and cellular functions J Cell Sci 122(21):3837-3850 Yamada Y, Post SR, Wang K, Tager HS, Bell GI, and Seino S (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney Proc Natl Acad Sci USA 89:251–255 Yoon HY, Miura K, Cuthbert EJ, Davis KK, Ahvazi B, Casanova JE, and Randazzo PA (2006) ARAP2 effects on the actin cytoskeleton are dependent on Arf6-specific GTPase-activating-protein activity and binding to RhoA-GTP J Cell Sci 119:4650–4666 Wang P, Wu Y, Ge X, Ma L, and Pei G (2003) Subcellular localization of βarrestins is determined by their intact N domain and the nuclear export signal at the C terminus J Biol Chem 278(13):11648-11653 War SA, Somvanshi RK, and Kumar U (2011) SSTR3 mediated intracellular signaling and apoptosis is regulated by its cytoplasmic terminal Biochim Biophys Acta Biochim Biophys Acta.1813(3):390-402 Watt HL, Kharmate GD, and Kumar U (2009) SSTR1 & heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells Cell Signal 21(3):428-439 92     White R E, Schonbrunn A, and Armstrong DL (1991) Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylation Nature 351:570– 573 Wolfe BL, and Trejo J (2007) Clathrin-dependent mechanisms of G proteincoupled receptor endocytosis Traffic 8(5):462-470 93     ACKNOWLEDGEMENTS I would like to take this opportunity to express my thanks to those who helped me with various aspects of conducting research and the writing of this dissertation First and foremost, I thank my major Professor, Dr Walter H Hsu for he guidance, patience and support throughout this research and the writing of this dissertation He insights and words of encouragement have often inspired me and renewed my hopes for completing my graduate education Special thank to Vietnamese Government for the financial support for my PhD program I would also like to thank my committee members for their efforts and contributions to this work (Dr Hsu, Dr Martin, Dr Kimber, Dr Day, Dr Carlson, and Dr Kanthasamy) I want to thank to my professors, teachers and colleagues from my faculty and my department members at Nong Lam University, Vietnam for their helps and taking care of my job at the department during my absence I would additionally like to thank Dr Anantharam for his guidance about research during my internship at PKBiosciences I am thankful Cathy Martens, Nada Pavlovic, Kim Adams, Linda Erickson, and Bill Robertson and other BMS staffs for their helps during my time at BMS, ISU My family is the most important thing in my life I am thankful for their supports, encourage, and always with me in difficult times, especially my wife, Dung Pham and the present of my little daughter Lan-Chi Ngoc Vo push me to finish this dissertation This work is in memory of my father-in-law who always encouraged us, but couldn’t wait to see my graduation Finally, I am grateful to all of my friends here in Ames (especially Yih Ho’s family, Nikki’s family, Anh Chy’s family, Hai-Hong, Huy-Huong, Lam-Chi, Hariharam, Huajun Jin, Ahmed, Prince, Nalee, Michael, Mostafa) for their helps, discussing and sharing opinions about research and life in general [...]... al., 2007) SSTR2A < /b> is < /b> the most distributed receptor isoform of SSTR2 in human tissues and neuroendocrine tumors In addition, SSTR2A < /b> is < /b> the physiologically active isoform between SSTR2A < /b> and SSTR 2B (Barnett, 2003) In RINm5F cells, SSTR2 is < /b> the predominant SSTR isoform (Vo unpublished data) Therefore, in this dissertation I will focus my study on SS -induced < /b> endocytosis < /b> and signaling pathway of SSTR2A < /b> As... These findings elucidated the interactions between signaling proteins in the GPCR endocytosis < /b> In contrast, Cohen et al (2007) reported that Arf6 was activated less by ARNO than EFA6 in HeLa and COS-7 cells EFA6 family includes EFA6A, EFA 6B, EFA6C, and EFA6D EFA6A, EFA6C, and EFA6D are primary expressed in the brain and intestine, whereas EFA 6B is < /b> broadly expressed, but is < /b> not detected in the brain (Derrien... from our lab determined that EFA6A existed in β -cells (Grodnitzky et al., 2007) Because the findings from our lab indicate that EFA6A mediates SS -induced < /b> PLD activity through < /b> Arf6- PLD cascade (Grodnitzky et al., 2007), we hypothesize that EFA6A -Arf6 mediates SS -induced < /b> SSTR2A < /b> endocytosis < /b> in β -cells 19     13 Arf GTPase activating proteins (Arf GAPs) As discussed above, GEFs turn on the signaling for... Domain structures of Arf GAP subfamilies Abbreviations are: ALPS, Arf GAP1 lipid-packing sensor; Arf GAP, Arf GAP domain; ANK, ankyrin repeat; BAR, Bin/Amphiphysin/Rvs; BoCCS, binding of coatomer, cargo and SNARE; CALM, CALM binding domain; CB, clathrin-box; CC, coiled-coil; FG repeats, multiple copies of the XXFG motif; GLD, GTP-binding protein-like domain; GRM, Glo3 regulatory motif; PBS, Paxillin binding... SS -induced < /b> PLD1 activation is < /b> mediated through < /b> EFA6A -Arf6 cascade (Grodnitzky et al., 2007) In RINm5F cells, we found both PLD1 and PLD2 (unpublished data) Therefore, we designed experiments to determine which PLD isoform was required for SS -induced < /b> SSTR2 endocytosis < /b> in RINm5F cells 15     10 PIP2 and endocytosis < /b> The lipid PIP2 accounts for only about 1% of total phospholipid in the plasma membrane,... publications regarding the involvement of Arfs in SSTRs endocytosis < /b> In this dissertation, I explored the role of Arf6 in the SS -induced < /b> endocytic signaling cascade for SSTR2A < /b> 12 GEFs and their role in endocytosis < /b> Arfs require GEFs to catalyze the exchange of GDP for GTP This group of proteins includes Gea/Gnom/GBF (Geal/2p, GBF1, Emb30/Gnom), Sec7/BIG (Sec7p, p200/BIG1/2, AL022604), ARNO/cytohesin/GRP... SS -induced < /b> SSTR2A < /b> endocytosis < /b> in β -cells is < /b> mediated by the β-arrestins -EFA6A -Arf6- PLD cascade Therefore, the objective of this dissertation is < /b> to elucidate the role of four important signal proteins (β-arrestins, EFA6A, Arf6, and PLD) and their interrelationships in the SS -induced < /b> SSTR2A < /b> endocytosis < /b> pathway I used RINm5F cells transiently overexpressed with SSTR2A < /b> as a model Cells were overexpressed... activation is < /b> required for receptor endocytosis < /b> and recycling and this endocytosis < /b> pathway is < /b> mediated by PLD2 (Rankovic et al., 2009) In angiotensin II type 1 receptor, Arf6 recruits AP2 and clathrin to receptor to activate the receptor endocytosis < /b> (Poupart et al., 2007) In addition, Arf6 is < /b> associated with clathrin-independent endocytosis < /b> in neuroblastoma cell (Kang et al., 2009) and beta 1 integrins (Dunphy... treatment of the cells with 1-butanol, a PLD inhibitor, inhibited endocytosis < /b> (Shen et al., 2001) These results confirmed the role of PLD in endocytosis < /b> PLD2, but not PLD1, has been shown to be required for endocytosis < /b> of µ-opioid receptor (Koch et al., 2004) and angiotensin II receptor (Du et al., 2004) In clonal β -cells HIT-T15, PLD1 is < /b> the only PLD isoform identified, which mediates SS -induced < /b> PIP2... Shenoy, 2005) In this dissertation, we used siRNAs as a molecular tool to knockdown β-arrestin 1 and β-arrestin 2 to explore which β-arrestin subtype is < /b> involved in SS -induced < /b> SSTR2A < /b> endocytosis < /b> in our cell model system 9 PLD and endocytosis < /b> PLD is < /b> a widely distributed enzyme that catalyzes the hydrolysis of phosphatidylcholine (PC) to form lipid second messenger phosphatidic acid (PA) (Jenkins and Frohman,